Ishitasuka K, Tamura K . Human T-cell leukaemia virus type 1 and adult T-cell leukaemia –lymphoma. Lancet Oncol. 2014; 15:517-526.
McKendall RR. Neurologic disease due to HTLV-1 infection . Handb. Clin. Neurol. 2014;123:507-530
Charles RMB , Lee Ratner. How does HTLV-1 cause adult T-cell leukaemia / lymphoma(ATL) ? Curr.Opin.Virol.2015;14:93-100.
Oliveira PD , Kachimarek AC, Biitencourt AL . Early onset of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T-cell leukaemia / lymphoma (ATL) : systematic search and review .J. Trop. Pediatr. 2018;64:151-161.
Poiesz BJ, Ruscetti FW , Reitz MS , Robert C. Isolation of a new type of C retrovirus (HTLV) in primary uncultured cells of a patient with Sezary T-cell leukaemia. Nature 1981;294(5838) : 268-271. doi : 10.1038/294268a0.
Verdonck K, Gonzalez E, Van DS, Gotuzzo E. Human T-lymphotropic virus-1 : Recent knowledge about an ancient infection . The Lancet Infectious Dieases 2007 ; 7(4) : 266-281 . doi:10.1016/S1473-3099(07) 70081-6.
Gonclaves DU, Proietti FA, Pinhiro SR, Proittic ABF. Epidemiology, treatment and prevention of human T-cell leukemia virus type- 1 associated diseases . Clinical Microbiology Reviews 2010;23(3):577-589.
Chihara D, Ito-H , Katanoda-K, Tajima K. Increase in incidence of adult T-cell leukaemia/lymphoma in non-endemic areas of Japan and the United States . Cancer Science 2012;103(10):1857-1860.
Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors . J . Med. Virol . 2012 ; 84(2): 327-335.
Nosaka K, Iwanaga M, Imaizumi Y, Ishida Y. Epidemiological and clinical features of adult T-cell leukaemia –lymphoma in Japan , 2010-2011:a nationwide survey. Cancer Sci. 2017;108:2478-2486.
Anat M, Hiroko Y, Michi M, Birney E, Charles RMB . The human leukaemia virus HTLV-1 alters the structure and transcription of host chromatin in cis. eLife 2018; Doi: 10. 7554/eLife.36245.
Araujo AQC. Update on neurological manifestations of HTLV-1 infection. Curr. Infect. Dis.Rep.2015;17:459.doi:10.1007/s 11908-014-0459-0.
Oliveira de, Neto JAC , Andrade RCP, Rocha PN . Risk factors for erectile dysfunction in men with HTLV-1 . J. Sex. Med.2017;14:1195-1200.
Lopes MAL, Rios GMF, Lacerda AJP, Paixao TS. Human T-lymphotropic virus-1 associated myelopathy/tropical spastic paraparesis is associated with sexual dysfunction in infected woman of reproductive age . Sex.Med.2018;6(4):324-331.
Gotuzzo E, Moody J, Verdonck K, Cabada MM ,Gonzalez E. Frequent HTLV-1 infection in the offspring of Peruvian women with HTLV-1-associated myelopathy/tropical spastic paraparesis of strongyloidiasis. Panam.Salud.Publica.2007;22:223-230.
Silva da JL, Rita PJR, Oliveira MFS , Farre L. Clustering of HTLV-1 associated myelopathy /tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil. J. Clin.Virol. 2013;58:482-485.doi.10.1016/ j.jcv.2013.07.012.
Bigger RJ, Kim N ,Hisada M, Li H, Cranston B. Human leucocyte antigen concordance and the transmission risk via breast feeding of human T-cell lymphotropic virus type 1. J.Infect.Dis.2006;193:277-282.doi:10.1086/948910.
Amor MM, Olaso AS, Cohen S, Kossev P. Adult T-cell leukaemia/lymphoma during pregnancy . Case Rep. Oncol. Med. 2013;631825. doi :10.1155/2013/631825.
Percher F, Jeannin P, Gessain A , Afonso PV . Mother to child transmission of HTLV-1 epidemiological aspects, mechanisms and determinants of mother –to-child transmission. Viruses 2016;8:E40.doi:10.3390/v/8020040.
Nicot C. Current views in HTLV-1 associated adult T-cell leukaemia/lymphoma. Am.J. Hematol. 2005; 78(3): 232 -239. doc:10.1002/ajh.20307.
Matsuoka M and Jeang K. Human T-cell leukaemia virus type-1 (HTLV-1) infectivity and cellular transformation . Nature Reviews Cancer 2007; 7(4): 270-280.
Marneros A, Grossman M, Sivers D, Connor O. Pralatrexate –induced tumor cell apoptosis in the dermis of patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions. Blood 2009 ; 113 (25): 6338-6341.
Subramaniam J, Whiteside G, McKeage K, Croxtall J. Mogamulizumab: first global approval. Drugs 2012;72(9): 1293-1298.